Browse diseases

…onist. Phase II data show tirzepatide is effective in resolving steatohepatitis in patients with MASLD with fibrosis at 52 weeks.2 However, no …

…ycaemic control (GC) is crucial for preventing complications of type 2 diabetes mellitus (T2DM) and remains a major public health challenge in Nepal, particula…

…ical scenarios: (1) preventing progression from pre-diabetes to T2DM through diet and exercise versus no intervention and natural di…

… populations and has demonstrated safety in pregnant women with systemic lupus erythematosus and rheumatoid diseases. In addition to its glucose-lowering ef…

…, as well as with all-cause mortality in Japanese patients with T2DM. As HDL-C may be both predictive and modifiable, clinicians sho…

…sociated with unacceptable practices.Conclusion Few people with T2DM presented good knowledge, right attitudes and adequate practice…

… in SAFE score corresponded to a 0.05-point increase in 10-year ASCVD risk, B=0.05, SE=0.005, p<0.001 (figure 1D). The findings sugge…

…Introduction Type 2 diabetes mellitus (T2DM) is a fast-growing chronic disease, with at least 1.3 million pe…

… eye disease, cerebrovascular disease, ischaemic heart disease, fatty liver disease and diabetic foot disease) and time-to-event analyses were perf…

…Introduction Type 2 diabetes mellitus (T2DM) is a chronic non-communicable disease that requires long-term m…

…ction was significantly higher (p < 0.05, n=12) in HSVSMCs from T2DM patients versus non-diabetic controls. Inhibition of MEK1/2-ERK…